Paul E. Goss

基本信息

Career Trajectory

Bio

Dr. Goss has personally cared for over 7000 cancer patients and designed and spearheaded clinical trials involving over 25,000 cancer patients in more than 55 countries. Dr. Goss is also a global cancer control expert having led multi-national teams of researchers to examine the state of cancer control in over half the world’s population including Latin America, China, India, and Russia. He has over 250 publications in leading international journals on cancer research and cancer control.

Research Interests

Papers共 507 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Adjunctive Statistical Standardization of Quantitated Adjuvant ER and PgR in CCTG MA.27

Judy-Anne Williams Chapman,Jane Bayani,Sandip SenGupta, John M. S. Battlett,Tammy Piper,Mary Anne Quintayo,Shakeel Virk,Paul E. Goss,James N. Ingle,Matthew James Ellis,George W. Sledge,George Thomas Budd,Manuela Rabaglio,Vered Stearns,Edith A. Perez,Karen A. Gelmon,Timothy Joseph Whelan,Lois E. Shepherd,Bingshu E. Chen,Karen J. Taylor

Journal of Clinical Oncologyno. 16_suppl (2024): 567-567

Cited0Views0Bibtex

Supplementary Figure S1 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

James N. Ingle,Fang Xie, Matthew J. Ellis,Paul E. Goss,Lois E. Shepherd, Judith-Anne W. Chapman, Bingshu E. Chen,Michiaki Kubo,Yoichi Furukawa,Yukihide Momozawa,Vered Stearns,Kathleen I. Pritchard,Poulami Barman,Erin E. Carlson,Matthew P. Goetz,Richard M. Weinshilboum,Krishna R. Kalari,Liewei Wang

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S2 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

James N. Ingle,Fang Xie, Matthew J. Ellis,Paul E. Goss,Lois E. Shepherd, Judith-Anne W. Chapman,Bingshu E. Chen,Michiaki Kubo,Yoichi Furukawa,Yukihide Momozawa,Vered Stearns,Kathleen I. Pritchard,Poulami Barman,Erin E. Carlson,Matthew P. Goetz,Richard M. Weinshilboum,Krishna R. Kalari,Liewei Wang

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer

Xiao-Jun Ma,Ranelle Salunga,Sonika Dahiya,Wilson Wang,Erin Carney,Virginie Durbecq,Adrian Harris,Paul Goss,Christos Sotiriou,Mark Erlander,Dennis Sgroi

openalex（2023）

Cited0Views0Bibtex

Supplementary Data Clean from Anastrozole Has an Association Between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor Α

James N. Ingle,Junmei Cairns, Vera J. Suman, Lois E. Shepherd,Peter A. Fasching, Tanya L. Hoskin,Ravinder J. Singh,Zeruesenay Desta,Krishna R. Kalari, Matthew J. Ellis,Paul E. Goss, Bingshu E. Chen,Bernhard Volz,Poulami Barman, Erin E. Carlson,Tufia Haddad,Matthew P. Goetz,Barbara Goodnature,Matthew E. Cuellar, Michael A. Walters, Cristina Correia,Scott H. Kaufmann,Richard M. Weinshilboum,Liewei Wang

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S4 from Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Founder

Papers共 507 篇Author StatisticsCo-AuthorSimilar Experts